Table 1.
Clinical and demographic characteristics of study subjects
| Variable | CTR | GC | P value |
|---|---|---|---|
| Sex (M/F) | 24/12 | 35/13 | 0.541 |
| Age (years) | 56.1 ± 9.2 | 55.9 ± 9.6 | 0.2066 |
| Neutrophils (109/l) | 3.46 ± 1.04 | 3.94 ± 1.31 | 0.68 |
| TAT (pg/ml) | 383 ± 60 | 714 ± 328 | < .0001 |
| D-dimers (ng/ml) | 92 ± 54 | 359 ± 296 | < .0001 |
| MPO-DNA (OD 405) | 0.076 ± 0.024 | 0.518 ± 0.507 | < .0001 |
| DNA (mg/ml) | 0.063 ± 0.027 | 0.463 ± 0.604 | < .0001 |
| Nucleosome (OD 405) | 0.128 ± 0.045 | 0.747 ± 0.62 | < .0001 |
| NE (ng/ml) | 1.76 ± 0.27 | 2.99 ± 1.04 | < .0001 |
| TNM stage | |||
| I | 7 | - | |
| II | 9 | - | |
| III | 25 | - | |
| IV | 7 | - | |
| Differentiation | |||
| Well | - | 3 | - |
| Moderate | - | 9 | - |
| Poor | - | 31 | - |
CTR, healthy controls; GC, gastric cancer; TAT, thrombin-antithrombin complex; OD, optic density; MPO, myeloperoxidase; NE, neutrophil elastase; TNM, tumor-node-metastasis.